Old Web
English
Sign In
Acemap
>
Paper
>
FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement?
FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement?
2021
Tazeen H. Jafar
Keywords:
Intensive care medicine
fda approval
Medicine
Kidney disease
Dapagliflozin
MEDLINE
Correction
Source
Cite
Save
Machine Reading By IdeaReader
18
References
2
Citations
NaN
KQI
[]